Mark Bailey

Mark Bailey has over 30 years of work experience in the pharmaceutical industry. Currently, they are serving as the Market Development Director for Liquidia Corporation, where they are devoted to developing therapies for patients with pulmonary arterial hypertension (PAH).

Prior to this, Mark worked at ACADIA Pharmaceuticals Inc. as the Area Director for the East Coast. In this role, they led a team of Regional Sales Managers and sales specialists and received the 2020 Sales Circle of Excellence Award.

Before joining ACADIA, Mark held the position of Regional Sales Director at Insmed Incorporated. Mark played a crucial role in developing targeted therapies for patients with rare diseases and improving the patient experience.

Mark also served as the Regional Business Director for Specialty Sales at Shire (formerly Baxalta) from 2014 to 2017. Mark received multiple awards for their exceptional performance and contributed to the development of therapeutic treatments for patients with rare conditions.

Earlier in their career, Mark worked at Amgen, where they held various roles such as Key Account Manager, Senior District Sales Manager, Marketing Manager, Oncology Sales Specialist, and Hepatology Sales Representative.

Prior to joining Amgen, they worked as a Specialty Sales Professional at Abbott, gaining valuable experience in the pharmaceutical industry.

Overall, Mark has demonstrated a strong commitment to improving patients' lives and has a proven track record of success in sales, marketing, and leadership roles within the pharmaceutical industry.

Mark Bailey attended the Fox School of Business at Temple University and obtained a Bachelor of Business Administration (BBA) degree with a major in Finance. The duration of their education is not specified.